1.
J Investig Allergol Clin Immunol
; 32(6): 496-498, 2022 12 15.
Article
in English
| MEDLINE
| ID: mdl-35118939
2.
J Investig Allergol Clin Immunol
; 32(3): 218-220, 2022 06 20.
Article
in English
| MEDLINE
| ID: mdl-34489234
Subject(s)
COVID-19 , Drug Hypersensitivity , Skin Diseases , Antiviral Agents , Drug Hypersensitivity/diagnosis , Humans , SARS-CoV-2
3.
J. investig. allergol. clin. immunol
; 32(3): 218-220, 2022.
Article
in English
| IBECS
| ID: ibc-203922
4.
J. investig. allergol. clin. immunol
; 32(6): 496-498, 2022. graf
Article
in English
| IBECS
| ID: ibc-213406
5.
J Eur Acad Dermatol Venereol
; 35(7): e425-e427, 2021 Jul.
Article
in English
| MEDLINE
| ID: mdl-33783873
Subject(s)
COVID-19 Vaccines , COVID-19 , Arm , BNT162 Vaccine , Health Personnel , Humans , RNA, Messenger , SARS-CoV-2
6.
J Investig Allergol Clin Immunol
; 31(6): 511-513, 2021 Dec 21.
Article
in English
| MEDLINE
| ID: mdl-33541850
7.
J. investig. allergol. clin. immunol
; 31(6): 511-513, 2021.
Article
in English
| IBECS
| ID: ibc-216782
Subject(s)
Humans , Female , Aged , Multiple Myeloma/drug therapy , Antineoplastic Agents, Immunological/adverse effects , Antineoplastic Agents, Immunological/therapeutic use , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/therapy , Desensitization, Immunologic , Severity of Illness Index
8.
J Eur Acad Dermatol Venereol
; 34(11): e659-e662, 2020 Nov.
Article
in English
| MEDLINE
| ID: mdl-32535943
Subject(s)
COVID-19/complications , Skin Diseases/virology , Adult , Biomarkers/blood , COVID-19/epidemiology , Female , Humans , Male , Middle Aged , Pandemics , SARS-CoV-2 , Skin Diseases/epidemiology
9.
J Investig Allergol Clin Immunol
; 27(5): 315-317, 2017.
Article
in English
| MEDLINE
| ID: mdl-29057738
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Mastocytosis/drug therapy , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Desensitization, Immunologic , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/etiology , Drug Hypersensitivity/therapy , Humans , Mastocytosis/complications , Mastocytosis/diagnosis , Treatment Outcome
10.
J. investig. allergol. clin. immunol
; 27(5): 315-317, 2017. tab
Article
in English
| IBECS
| ID: ibc-167251
ABSTRACT
No disponible